| 000 | 01346 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250517163321.0 | ||
| 264 | 0 | _c20180416 | |
| 008 | 201804s 0 0 eng d | ||
| 022 | _a1536-3694 | ||
| 024 | 7 |
_a10.1097/FTD.0000000000000421 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMedina, Frédéric | |
| 245 | 0 | 0 |
_aCurrent Practice for Therapeutic Drug Monitoring of Biopharmaceuticals in Rheumatoid Arthritis. _h[electronic resource] |
| 260 |
_bTherapeutic drug monitoring _c08 2017 |
||
| 300 |
_a364-369 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xblood |
| 650 | 0 | 4 |
_aAntirheumatic Agents _xblood |
| 650 | 0 | 4 |
_aArthritis, Rheumatoid _xdrug therapy |
| 650 | 0 | 4 |
_aBiological Products _xblood |
| 650 | 0 | 4 |
_aBiopharmaceutics _xmethods |
| 650 | 0 | 4 |
_aDrug Monitoring _xmethods |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xantagonists & inhibitors |
| 700 | 1 | _aPlasencia, Chamaida | |
| 700 | 1 | _aGoupille, Philippe | |
| 700 | 1 | _aTernant, David | |
| 700 | 1 | _aBalsa, Alejandro | |
| 700 | 1 | _aMulleman, Denis | |
| 773 | 0 |
_tTherapeutic drug monitoring _gvol. 39 _gno. 4 _gp. 364-369 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/FTD.0000000000000421 _zAvailable from publisher's website |
| 999 |
_c27360736 _d27360736 |
||